CTSO vs HOOD · rev $18.5M vs P/E 48, rev $2.38B
Cytosorbents Crp (CTSO) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
CTSO currently screens at market cap $28.8M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the CTSO and HOOD stock pages for the full models.
Not investment advice.